NCT04243980

Brief Summary

A study that detect the femoral anteversion after total hip arthroplasty using short anatomical femoral stem compared to the contrast side

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Feb 2020

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 23, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

January 28, 2020

Completed
4 days until next milestone

Study Start

First participant enrolled

February 1, 2020

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2021

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2022

Completed
Last Updated

January 28, 2020

Status Verified

January 1, 2020

Enrollment Period

11 months

First QC Date

January 23, 2020

Last Update Submit

January 26, 2020

Conditions

Patient CompliancePatient Satisfaction

Outcome Measures

Primary Outcomes (1)

  • Femoral anteversion

    comparing femoral anteversion after THR using CT scan

    Post-Operatively, through study completion, an average of 2 years

Secondary Outcomes (1)

  • Harris Hip Score

    6 weeks, 3 month, 6 month post-operative

Study Arms (1)

Group 1

Patients after total hip arthroplasty with short femoral stem

Device: Short anatomical femoral stem in THR

Interventions

Short anatomical femoral stem in THRDEVICE

Patients with osteoarthritis after total hip arthroplasty

Group 1

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients aged 18 - 90 who had THR as an elective surgery

You may qualify if:

  • age 18-90
  • patients who had THR as an elective surgery
  • patients who had THR with short femoral anatomical stem

You may not qualify if:

  • severe osteoporosis with Dorr C classification
  • s/p bilateral hip arthroplasty
  • non-complaint patients
  • revision surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Patient CompliancePatient Satisfaction

Condition Hierarchy (Ancestors)

Patient Acceptance of Health CareTreatment Adherence and ComplianceHealth BehaviorBehavior

Central Study Contacts

Raja Hakim, M.D.

CONTACT

00972546612251raja.hakim@icloud.com

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Doctor

Study Record Dates

First Submitted

January 23, 2020

First Posted

January 28, 2020

Study Start

February 1, 2020

Primary Completion

January 1, 2021

Study Completion

January 1, 2022

Last Updated

January 28, 2020

Record last verified: 2020-01

Data Sharing

IPD Sharing
Will not share